The inflammatory suppression and antiangiogenic function offered by thalidomide may be beneficial for glioma patients with severe inflammatory factors infiltration‐dependent angiogenesis, which further highlights the crucial role of inflammation in angiogenesis and regulatory role of NF‐κB. This evidence concerns the gene NFKB1 and glioma.